OPTIMIZING THE USE OF RISK FACTORS TO GUIDE THE COST-EFFECTIVE USE OF PALIVIZUMAB PROPHYLAXIS AGAINST SEVERE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN KOREAN INFANTS BORN 32-35 WEEKS' GESTATIONAL AGE Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Keary, I
  • Kang, JM
  • Paes, B
  • Rodgers-Gray, B
  • Fullarton, J
  • Tarride, Jean-Eric
  • Yang, HJ
  • Chang, YS
  • Carbonell-Estrany, X

publication date

  • December 2023